Scilex Holding Co (SMNR) details 13.97M Semnur stock dividend and abeyance
Rhea-AI Filing Summary
Scilex Holding Co, a major holder of Semnur Pharmaceuticals, Inc., reported a previously announced stock dividend of 13,972,900 shares of Semnur common stock distributed to its own common shareholders and certain warrant and convertible note holders as of a June 1, 2026 record date.
The filing notes that 6,938,163 of these dividend shares are being held in abeyance for additional participating warrant and note holders, to be distributed if and when those instruments are exercised or converted, with a separate Form 4 to be filed at that time. The report also shows a J-code restructuring entry for 7,034,737 Semnur common shares at a stated price of $0.0000 per share and updated direct and indirect ownership positions, including shares held through Scilex, Inc. and Scilex Bio, Inc.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock | 7,034,737 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- On June 15, 2026, the Reporting Person paid its previously announced stock dividend (the "Dividend") consisting of an aggregate of 13,972,900 shares of common stock of Semnur Pharmaceuticals, Inc. ("Semnur") held by the Reporting Person (the "Dividend Shares") to record holders of (i) the Reporting Person's common stock, (ii) certain warrants to purchase the Reporting Person's common stock and (iii) certain notes convertible into shares of the Reporting Person's common stock as of June 1, 2026 (the "Record Date" and the holders referenced in clauses (ii) and (iii), the "Additional Participating Holders"). An aggregate of 6,938,163 Dividend Shares are being held in abeyance by the Reporting Person for the benefit of the Additional Participating Holders who may be entitled to such shares pursuant to the terms of the applicable warrants and convertible notes following the exercise or conversion thereof, and at the time such shares are distributed to the applicable warrantholders and noteholders, the Reporting Person will file a Form 4 reporting such distribution.